Sam OHara
Director Umoja Biopharma
Product Sciences group and Analytical Lead for multiple clinical and pre-clinical stage programs and Established Product Sciences group responsible for product understanding of In Vivo CAR T cell therapies. Her team develops characterization methods to link critical viral attributes to functional CAR T cell responses and supports multiple INDs and regulatory filings. She previously Led the mechanistic biology team developing in vitro and in vivo models for immunotherapy drug lead selection at Zoetis and held immunology roles at Merck. She holds a PhD from the University of Colorado Boulder and a BS from Florida State University.
